IRCT20161204031229N3招募中3 期
Study of the Efficacy of Teicoplanin on mortality rate of patients with COVID-19 Infection: A randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Laboratory confirmed COVID-19 with RT-PCR
- •Laboratory confirmed COVID-19 with lung CT scan
排除标准
- •Chronic kidney Disease
- •Acute kidney injury
- •Breastfeeding
研究者
相似试验
已完成
3 期
A comparison of therapeutic effects of teicoplanin versus vancomycin in patients admitted to the Intensive Care Unit after cardiac surgeryEndocarditis.Acute endocarditis, unspecifiedIRCT2016022220592N4Shahid Beheshti University of Medical Sciences46
已完成
2 期
Comparison between effects of Teicoplanin versus Vancomycin in treatment of catheter infection in hemodialysis patientshemodialysis patients who had catheter infection.Other infectious diseasesA00-B99IRCT138903234144N2Semnan university of medical sciences43
终止
4 期
Efficacy and Safety of Teicoplanin in CDADClostridium Difficile Infection-associated Diarrhea and ColitisNCT04003818Sanofi50
招募中
不适用
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia(Pediatric) Acute myeloid leukemiaNL-OMON29284Princess Máxima Center for Pediatric Oncology130
已完成
4 期
Teicoplanin Prophylaxis for Total Hip or Knee ArthroplastyTotal Hip and Knee ArthroplastiesNCT00719056University of Athens616